Category Archives: (Sandbox Syndication Account) Health News (Master Feed)
Abcam shareholders approve $5.7 billion Danaher deal
(Reuters) -Abcam shareholders on Monday approved the proposal from Danaher Corp to acquire all outstanding shares of the company for $24 per share in cash. Danaher agreed to buy Abcam in September in ...
Nov 06, 2023
Exclusive-Cigna explores shedding Medicare Advantage business -sources
By David Carnevali NEW YORK (Reuters) - U.S. health insurer Cigna Group is exploring the sale of its Medicare Advantage business, which provides additional benefits to those covered by federal health ...
Nov 06, 2023
England’s young cystic fibrosis patients face new treatment worry
By Andy Bruce MANCHESTER, England (Reuters) - Young English sufferers of cystic fibrosis (CF) face new uncertainty after regulators published proposals which, if enacted, would restrict access to pote...
Nov 06, 2023
Swiss-designed technology helps Parkinson’s patient walk again
By Cecile Mantovani and Gabrielle Ttrault-Farber LAUSANNE, Switzerland (Reuters) - A long-term Parkinson's disease patient, Marc Gauthier had essentially been confined to his home until he became the ...
Nov 06, 2023
Bristol Myers buys Orum’s blood cancer therapy for up to $180 million
(Reuters) - Bristol Myers Squibb has acquired Orum Therapeutics' experimental therapy to treat a type of blood cancer for a total value of up to $180 million, the privately held company said on Monday...
Nov 06, 2023
US CDC to expand surveillance of travelers for respiratory viruses
(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) will expand its traveler-based surveillance program to include testing for respiratory viruses, partners Ginkgo Bioworks and XWELL...
Nov 06, 2023
BioNTech cuts 2023 revenue target on reduced prospects for vaccine
FRANKFURT (Reuters) - BioNTech has cut its 2023 revenue target by about 1 billion euros ($1.1 billion) on lower demand for the COVID-19 vaccine made with Pfizer but said the impact from write-downs at...
Nov 06, 2023
India’s Gland Pharma misses Q2 profit view on higher expenses
BENGALURU (Reuters) - Indian generic injectables maker Gland Pharma posted a weaker-than-expected second-quarter profit on Monday, as higher employee expenses eclipsed strong sales in key markets. The...
Nov 06, 2023
India’s Max Healthcare Institute reports 38% rise in Q2 pre-tax profit
(BENGALURU) (Reuters) - India's Max Healthcare Institute on Monday reported a 38% rise in its second-quarter profit before tax, as it earned more revenue per bed. The hospital and diagnostic services ...
Nov 06, 2023
Rugby-World Rugby welcomes largest ever head impact study in community game
SYDNEY (Reuters) - World Rugby chief Bill Beaumont has welcomed the largest ever study of the impact of collisions on the heads of players as proof that the game is serious about becoming a global lea...
Nov 06, 2023
